跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Glusimet - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Glusimet
Approved
STANDARD
Glusimet
Scilife Pharma (Pvt.) Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1e60bc9efdbb4c44
Company
Scilife Pharma (Pvt.) Ltd.
Type
Standard
Approval Details
Approval Id
1e60bc9efdbb4c44
Drug Approval Philippines Name
Glusimet
Product Name
Glusimet
Registration Number
DRP-12905
Brand Name
Glusimet
Generic Name
Sitagliptin + Metforinin Hydrochloride
Dosage Form
Film-Coated Tablet
Dosage Strength
50mg/1000mg
Manufacturer
Scilife Pharma (Pvt.) Ltd.
Importer
SMHP Pharmaceuticals Incorporated
Distributor
SMHP Pharmaceuticals Incorporated
Issuance Date
27 October 2022
Expiry Date
27 October 2027
Pharmacologic Category
Combination of Oral Blood Glucose Lowering Drugs
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1e60bc9efdbb4c44
Type
Standard
Back to Philippines FDA Approvals